Glatiramer Acetate
NDC 0378-6961, Glatiramer, injection, solution, from Mylan Pharmaceuticals Inc..
- Product NDC
- 0378-6961
- Status
- Listed
- Labeler
- Mylan Pharmaceuticals Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA206936
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0378-6961 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GLATIRAMER ACETATE40 mg/mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0378-6961-12 | 00378696112 | 12 BLISTER PACK in 1 CARTON (0378-6961-12) / 1 SYRINGE in 1 BLISTER PACK (0378-6961-32) / 1 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/456a34c7-8511-4000-99a7-ad8f8de6d35eNADAC price for package 00378696112
GET /v1/drugs/nadac/00378696112
Use it
Look up 0378-6961 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0378-6961 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0378-6961. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.